IHAM
RAPT

Integral Health Asset Management’s RAPT Therapeutics RAPT Stock Holding History

Integral Health Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,625
Closed -$2.16M – 86
2022
Q4 		$2.16M Buy
+13,625
New +$2.18M 0.45% 56

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Integral Health Asset Management's RAPT Position: Q1 2023 in Review

Integral Health Asset Management sold out of RAPT Therapeutics (RAPT) in Q1 2023, closing a stake of 13,625 shares — an estimated $2.16M sold.

Integral Health Asset Management first reported a position in RAPT in Q4 2022 and held it in 1 quarter. The position peaked at $2.16M in Q4 2022. 106 funds tracked by Wall St. Rank hold RAPT as of Q1 2023.

  • Integral Health Asset Management reported no remaining RAPT Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Integral Health Asset Management sold 13,625 RAPT Therapeutics shares in Q1 2023, an estimated $2.16M.
  • Integral Health Asset Management first reported a position in RAPT Therapeutics in Q4 2022 and held it in 1 quarter.
  • Integral Health Asset Management's RAPT Therapeutics position peaked at $2.16M in Q4 2022.
  • 106 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2023.

Based on Integral Health Asset Management's 13F filing for Q1 2023, filed 9 May 2023.